M
Maptimmune is focused on developing novel therapeutics specifically targeting Alzheimer's disease. The company is advancing a new generation of treatments to address this neurodegenerative condition. Their work centers on creating innovative pharmacological solutions for Alzheimer's intervention.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Maptimmune focuses on developing novel therapeutics specifically targeting Alzheimer's disease. The company is creating the next generation of treatments to address the underlying pathology of this neurodegenerative condition. Their work aims to provide new therapeutic options for patients suffering from Alzheimer's.